KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Liabilities (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Total Liabilities for 8 consecutive years, with $287.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 14.59% to $287.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $287.7 million through Dec 2025, down 14.59% year-over-year, with the annual reading at $287.7 million for FY2025, 14.59% down from the prior year.
  • Total Liabilities hit $287.7 million in Q4 2025 for Adaptive Biotechnologies, roughly flat from $286.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $396.4 million in Q3 2022 to a low of $286.4 million in Q3 2025.
  • Historically, Total Liabilities has averaged $337.3 million across 5 years, with a median of $340.6 million in 2021.
  • Biggest five-year swings in Total Liabilities: decreased 15.22% in 2022 and later grew 27.84% in 2023.
  • Year by year, Total Liabilities stood at $319.2 million in 2021, then grew by 22.95% to $392.5 million in 2022, then decreased by 10.1% to $352.9 million in 2023, then dropped by 4.52% to $336.9 million in 2024, then dropped by 14.59% to $287.7 million in 2025.
  • Business Quant data shows Total Liabilities for ADPT at $287.7 million in Q4 2025, $286.4 million in Q3 2025, and $317.1 million in Q2 2025.